Our Recommendations
- Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy (2022)
- Chronic Care for Neglected Infectious Diseases: Leprosy/ Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease (2021)
- Lymphatic Filariasis and Podoconiosis morbidity management and disability prevention guidelines (2016)
- Bench Aids for the diagnosis of filarial infections (1997)
- Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition (2021)
Filter
51
Featured
Recommendations
7
New Publications
1
Language
Document type
Studies & Reports
22
Guidelines
10
Videos
5
Manuals
4
Infographics
3
Strategic & Response Plan
3
Training Material
2
App
1
Fact sheets
1
Countries / Regions
Global
18
Africa
2
Latin America and the Carribbean
1
Saudi Arabia
1
Western Pacific Region
1
Djibouti
1
Egypt
1
Sudan
1
Yemen
1
Ethiopia
1
Zambia
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Lymphaticfilariasis
4
Countries
3
Trachoma
1
Dermatology
1
Chagas
1
Guidelines
1
Disabilities
1
Studies & Reports
1
Leprosy
1
Parasitology
1
Toolboxes
Studies & Reports
14
Clinical Aspects & Diagnostics
13
Information & Education Material (IEC)
8
Statistics & Facts
7
Prevention & Control
7
Capacity Building & Resources
6
The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout...
In South and Central America, lymphatic filariasis (LF) is caused by Wuchereria bancrofti, which is transmitted by Culex quinquefasciatus, the only vector species in this region. Of the seven countries considered endemic for LF in the Americas in the last decade, Costa Rica, Suriname and Trinidad a...
Lymphatic filariasis (LF), a neglected tropical disease, is targeted for global elimination as a public health problem. This article reviews the history of LF control and elimination activities in the countries of the World Health Organization's (WHO) Eastern Mediterranean Region (EMR) over the last...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
Lymphatic filariasis (LF) is a preventable neglected tropical disease (NTD) caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi or B. timori. Mosquitos in the genera Culex, Anopheles, Mansonia and Aedes transmit the parasites from person to person. Lymphoedema and hyd...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
